- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有166家主力机构披露2025-06-30报告期持股数据，持仓量总计4.50亿股，占流通A股78.83%
- 波段诊断：
-
技术面诊股
诊断结果：6.4技术面打败了50%的股票
技术面评分前10的股票
近期的平均成本为38.39元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为38.39元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"38.39","date":1760260670,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，接近行业平均水平。
[{"date":"2025.10.13","stock":"-1.54","trade":null,"ind":"-0.19"},{"date":"2025.10.10","stock":"-0.61","trade":null,"ind":"-0.94"},{"date":"2025.10.09","stock":"0.10","trade":null,"ind":"1.32"},{"date":"2025.09.30","stock":"0.00","trade":null,"ind":"0.52"},{"date":"2025.09.29","stock":"-0.41","trade":null,"ind":"0.90"},{"date":"2025.09.26","stock":"-0.58","trade":null,"ind":"-0.65"},{"date":"2025.09.25","stock":"-0.88","trade":null,"ind":"-0.01"},{"date":"2025.09.24","stock":"1.71","trade":null,"ind":"0.83"},{"date":"2025.09.23","stock":"-1.48","trade":null,"ind":"-0.18"},{"date":"2025.09.22","stock":"-0.94","trade":null,"ind":"0.22"},{"date":"2025.09.19","stock":"-0.67","trade":null,"ind":"-0.30"},{"date":"2025.09.18","stock":"-1.03","trade":null,"ind":"-1.15"},{"date":"2025.09.17","stock":"-0.27","trade":null,"ind":"0.37"},{"date":"2025.09.16","stock":"-0.05","trade":null,"ind":"0.04"},{"date":"2025.09.15","stock":"-0.17","trade":null,"ind":"-0.26"},{"date":"2025.09.12","stock":"-1.41","trade":null,"ind":"-0.12"},{"date":"2025.09.11","stock":"0.99","trade":null,"ind":"1.65"},{"date":"2025.09.10","stock":"-1.92","trade":null,"ind":"0.13"},{"date":"2025.09.09","stock":"-0.57","trade":null,"ind":"-0.51"},{"date":"2025.09.08","stock":"4.46","trade":null,"ind":"0.38"},{"date":"2025.09.05","stock":"0.55","trade":null,"ind":"1.24"}]
安图生物,上证指数,医疗器械指数
压力支撑
该股压力位为38.38元，支撑位为38.14元。
[{"text":"\u538b\u529b\u4f4d","value":"38.38","date":1760284800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"38.14","date":1760284800,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：5.0资金面打败了61%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：10月13日 20:39
| 机构今日流向(万元) | -230.57 | 机构5日流向(万元) | -1161.12 |
| 机构10日流向(万元) | -3246.00 | 机构20日流向(万元) | -12603.13 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少1507.6万股，其中基金净减仓76家，主力净减仓82家，请投资者中长期谨慎为宜。
截止2025-06-30，共166家主力机构（基金163家，一般法人3家），持仓量总计45046.36万股，占流通A股78.83%
其中，基金持仓与2024-12-31相比：
增仓：22家 ，增持 169.21万股
减仓：98家 ，减持 703.13万股
新出现在主力名单中：38家 ，持有1141.82万股
从主力名单中消失：120家 ，原持有1188.76万股
其中，基金持仓与2024-12-31相比：
增仓：22家 ，增持 169.21万股
减仓：98家 ，减持 703.13万股
新出现在主力名单中：38家 ，持有1141.82万股
从主力名单中消失：120家 ，原持有1188.76万股
消息面诊股
诊断结果：5.5消息面打败了68%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 2025年中国医疗耗材行业十大潜力企业排行榜（附榜
2025-10-11 - 安图生物：10月10日获融资买入701.10万元
2025-10-11 - 医疗器械及精准医疗产业与投资一周热点回顾
2025-10-10 - 永不掉速的研发“高铁”
2025-10-10 - 安图生物：10月9日获融资买入1323.55万元
2025-10-10 - 上市医疗器械公司销售费用公布（附名单）
2025-10-09 - 安图生物：9月30日获融资买入1039.89万元
2025-10-01 - 安图生物：9月29日获融资买入911.20万元
2025-09-30 - 券商观点|医药生物行业周报：关税实际影响小，下跌为
2025-09-29 - 安图生物全自动微生物培养监测仪AutoBes X系
2025-09-29
消息列表
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-22 |
| 一般消息 | 募资投向 | 2025-08-21 | |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-04-18 |
| 利好 | 分红转增 | 10派12.60元(含税) | 2025-04-18 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-02-17 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-01-21 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2024-12-10 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：0.0行业面打败了9%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2025.10.13","price":"-0.19","value":null},{"date":"2025.10.10","price":"-0.94","value":null},{"date":"2025.10.09","price":"1.32","value":null},{"date":"2025.09.30","price":"0.52","value":null},{"date":"2025.09.29","price":"0.90","value":null},{"date":"2025.09.26","price":"-0.65","value":null},{"date":"2025.09.25","price":"-0.01","value":null},{"date":"2025.09.24","price":"0.83","value":null},{"date":"2025.09.23","price":"-0.18","value":null},{"date":"2025.09.22","price":"0.22","value":null},{"date":"2025.09.19","price":"-0.30","value":null},{"date":"2025.09.18","price":"-1.15","value":null},{"date":"2025.09.17","price":"0.37","value":null},{"date":"2025.09.16","price":"0.04","value":null},{"date":"2025.09.15","price":"-0.26","value":null},{"date":"2025.09.12","price":"-0.12","value":null},{"date":"2025.09.11","price":"1.65","value":null},{"date":"2025.09.10","price":"0.13","value":null},{"date":"2025.09.09","price":"-0.51","value":null},{"date":"2025.09.08","price":"0.38","value":null},{"date":"2025.09.05","price":"1.24","value":"-357279036.44"}]
上证指数,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 振德医疗 | 139.56% | 41.12% | 5.9分 |
| 2 | 奥精医疗 | 19.67% | 1.30% | 4.9分 |
| 3 | 海泰新光 | 18.14% | 3.38% | 6.0分 |
| 4 | 浩欧博 | 15.62% | -0.38% | 4.7分 |
| 5 | 康为世纪 | 15.39% | 4.54% | 4.9分 |
| 6 | 华兰股份 | 14.85% | -9.54% | 5.9分 |
| 8 | 楚天科技 | 13.01% | 1.10% | 5.1分 |
| 10 | 英科医疗 | 11.26% | 2.41% | 5.8分 |
| 12 | 麦克奥迪 | 10.80% | -1.66% | 5.7分 |
| 14 | 大博医疗 | 8.48% | 11.24% | 6.7分 |
| 16 | 联影医疗 | 7.28% | 6.04% | 6.0分 |
| 18 | 澳华内镜 | 7.00% | 3.95% | 5.3分 |
| 20 | ST凯利 | 5.90% | 0.68% | 5.6分 |
| 22 | 开立医疗 | 5.51% | 0.35% | 4.5分 |
| 24 | 华强科技 | 3.75% | 10.29% | 5.5分 |
| 26 | 天智航 | 3.06% | 3.97% | 5.6分 |
| 28 | 普门科技 | 2.54% | 5.68% | 6.1分 |
| 30 | 海尔生物 | 1.72% | 2.70% | 6.1分 |
| 32 | 万东医疗 | 1.34% | -2.47% | 5.4分 |
| 34 | 心脉医疗 | 0.78% | -1.25% | 5.5分 |
| 36 | 可孚医疗 | 0.20% | 6.16% | 6.3分 |
| 38 | 黄山胶囊 | -0.26% | 0.94% | 6.0分 |
| 40 | 港通医疗 | -0.46% | 0.94% | 5.3分 |
| 42 | 万泰生物 | -0.59% | 2.43% | 4.6分 |
| 44 | 赛科希德 | -0.79% | 0.27% | 5.4分 |
| 46 | 九安医疗 | -1.14% | -0.91% | 5.3分 |
| 48 | 东星医疗 | -1.19% | -2.00% | 5.2分 |
| 50 | 爱威科技 | -1.26% | 2.34% | 6.1分 |
| 52 | 新产业 | -1.55% | -6.37% | 5.0分 |
| 54 | 拱东医疗 | -1.70% | 1.11% | 5.5分 |
| 56 | 济民健康 | -1.81% | -3.64% | 4.3分 |
| 58 | 奕瑞科技 | -1.99% | -0.98% | 5.6分 |
| 60 | 西山科技 | -2.20% | 1.45% | 5.3分 |
| 62 | 迈普医学 | -2.28% | -3.49% | 5.1分 |
| 64 | 天益医疗 | -2.44% | -0.16% | 5.6分 |
| 66 | 科美诊断 | -2.64% | 1.71% | 5.5分 |
| 68 | 山东药玻 | -3.11% | -0.52% | 5.4分 |
| 70 | 凯普生物 | -3.28% | -0.36% | 4.8分 |
| 72 | 南卫股份 | -3.34% | 0.00% | 5.9分 |
| 74 | 超研股份 | -3.49% | -0.45% | 4.8分 |
| 76 | 爱迪特 | -3.58% | -0.70% | 5.5分 |
| 78 | 正川股份 | -3.78% | -1.43% | 4.6分 |
| 80 | 美康生物 | -4.11% | 0.00% | 4.6分 |
| 82 | 康拓医疗 | -4.44% | 0.08% | 5.6分 |
| 84 | 中红医疗 | -4.80% | -0.15% | 5.5分 |
| 86 | 九强生物 | -5.29% | -1.05% | 5.2分 |
| 88 | 宝莱特 | -5.43% | -0.83% | 4.9分 |
| 90 | 奥美医疗 | -5.48% | 0.53% | 6.0分 |
| 92 | 尚荣医疗 | -5.52% | 0.51% | 4.9分 |
| 94 | 翔宇医疗 | -5.67% | 3.11% | 5.7分 |
| 96 | 阳普医疗 | -5.71% | -0.13% | 5.3分 |
| 98 | 瑞迈特 | -5.75% | 2.88% | 5.9分 |
| 100 | 国发股份 | -5.81% | 5.04% | 5.8分 |
| 102 | 威高血净 | -6.00% | -0.47% | 5.8分 |
| 104 | 昊海生科 | -6.50% | -0.21% | 5.6分 |
| 106 | 理邦仪器 | -6.72% | -1.27% | 5.3分 |
| 108 | 戴维医疗 | -6.91% | -0.51% | 5.5分 |
| 110 | 微电生理 | -7.03% | -3.31% | 5.2分 |
| 112 | 三鑫医疗 | -7.06% | 0.33% | 5.4分 |
| 114 | 乐普医疗 | -7.42% | -1.61% | 4.5分 |
| 116 | 欧普康视 | -7.86% | 0.06% | 4.9分 |
| 118 | 之江生物 | -8.44% | -0.62% | 4.8分 |
| 120 | 美好医疗 | -8.53% | -3.56% | 5.5分 |
| 122 | 艾德生物 | -8.91% | 0.53% | 5.6分 |
| 124 | 康众医疗 | -13.65% | -9.29% | 4.7分 |
| 126 | 爱朋医疗 | -14.27% | 2.02% | 4.7分 |
| 128 | - | -14.37% | -6.14% | 分 |
| 130 | - | -14.64% | -0.14% | 分 |
| 132 | 易瑞生物 | -22.39% | -2.97% | 5.2分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 16/247 ， 41/247。
[{"date":"2025-06-30","value":"6.69","vol":"2.27"},{"date":"2025-03-31","value":"3.09","vol":"1.15"},{"date":"2024-12-31","value":"13.93","vol":"0.53"},{"date":"2024-09-30","value":"11.29","vol":"4.75"},{"date":"2024-06-30","value":"7.37","vol":"3.53"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
6.69 | 3.09 | 13.93 | 11.29 | 7.37 |
| 行业(%) | 2.27 | 1.15 | 0.53 | 4.75 | 3.53 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"64.43","vol":"52.10"},{"date":"2025-03-31","value":"65.07","vol":"51.81"},{"date":"2024-12-31","value":"65.41","vol":"52.63"},{"date":"2024-09-30","value":"65.86","vol":"53.58"},{"date":"2024-06-30","value":"65.37","vol":"53.70"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
64.43 | 65.07 | 65.41 | 65.86 | 65.37 |
| 行业(%) | 52.10 | 51.81 | 52.63 | 53.58 | 53.70 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 78/247 ， 56/247。
[{"date":"2025-06-30","value":"-6.65","vol":"-1.71"},{"date":"2025-03-31","value":"-8.56","vol":"-0.92"},{"date":"2024-12-31","value":"0.62","vol":"0.64"},{"date":"2024-09-30","value":"4.24","vol":"0.79"},{"date":"2024-06-30","value":"4.70","vol":"0.16"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-6.65 | -8.56 | 0.62 | 4.24 | 4.70 |
| 行业(%) | -1.71 | -0.92 | 0.64 | 0.79 | 0.16 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"-7.83","vol":"-20.27"},{"date":"2025-03-31","value":"-16.76","vol":"-4.25"},{"date":"2024-12-31","value":"-1.89","vol":"-24.11"},{"date":"2024-09-30","value":"6.13","vol":"-20.40"},{"date":"2024-06-30","value":"13.49","vol":"8.56"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-7.83 | -16.76 | -1.89 | 6.13 | 13.49 |
| 行业(%) | -20.27 | -4.25 | -24.11 | -20.40 | 8.56 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 46/247 ， 94/247。
[{"date":"2025-06-30","value":"0.18","vol":"0.17"},{"date":"2025-03-31","value":"0.08","vol":"0.08"},{"date":"2024-12-31","value":"0.38","vol":"0.35"},{"date":"2024-09-30","value":"0.29","vol":"0.26"},{"date":"2024-06-30","value":"0.20","vol":"0.18"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.18 | 0.08 | 0.38 | 0.29 | 0.20 |
| 行业(次) | 0.17 | 0.08 | 0.35 | 0.26 | 0.18 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.65","vol":"1.13"},{"date":"2025-03-31","value":"0.30","vol":"0.55"},{"date":"2024-12-31","value":"1.60","vol":"2.33"},{"date":"2024-09-30","value":"1.35","vol":"1.67"},{"date":"2024-06-30","value":"0.92","vol":"1.13"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.65 | 0.30 | 1.60 | 1.35 | 0.92 |
| 行业(次) | 1.13 | 0.55 | 2.33 | 1.67 | 1.13 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 45/247 ， 73/247。
[{"date":"2025-06-30","value":"22.91","vol":"15.06"},{"date":"2025-03-31","value":"16.70","vol":"4.01"},{"date":"2024-12-31","value":"33.02","vol":"29.58"},{"date":"2024-09-30","value":"38.66","vol":"15.37"},{"date":"2024-06-30","value":"14.95","vol":"13.04"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 22.91 | 16.70 | 33.02 | 38.66 | 14.95 |
| 行业 | 15.06 | 4.01 | 29.58 | 15.37 | 13.04 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.32","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.30","vol":"2.19"},{"date":"2024-09-30","value":"","vol":"0.01"},{"date":"2024-06-30","value":"1.53","vol":"2.31"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 1.32 | - | 1.30 | - | 1.53 |
| 行业 | 1.57 | 0.00 | 2.19 | 0.01 | 2.31 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 13/247 ， 7/247。
[{"date":"2025-06-30","value":"2.34","vol":"5.50"},{"date":"2025-03-31","value":"2.62","vol":"5.89"},{"date":"2024-12-31","value":"2.46","vol":"5.34"},{"date":"2024-09-30","value":"2.57","vol":"5.97"},{"date":"2024-06-30","value":"2.71","vol":"5.95"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.34 | 2.62 | 2.46 | 2.57 | 2.71 |
| 行业 | 5.50 | 5.89 | 5.34 | 5.97 | 5.95 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.85","vol":"4.40"},{"date":"2025-03-31","value":"0.65","vol":"4.77"},{"date":"2024-12-31","value":"0.65","vol":"4.32"},{"date":"2024-09-30","value":"0.89","vol":"4.82"},{"date":"2024-06-30","value":"0.99","vol":"4.90"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.85 | 0.65 | 0.65 | 0.89 | 0.99 |
| 行业 | 4.40 | 4.77 | 4.32 | 4.82 | 4.90 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 39/247 ， 42/247。
[{"date":"2025-06-30","value":"26.57","vol":"22.01"},{"date":"2025-03-31","value":"25.05","vol":"21.24"},{"date":"2024-12-31","value":"26.81","vol":"21.92"},{"date":"2024-09-30","value":"25.49","vol":"21.09"},{"date":"2024-06-30","value":"24.22","vol":"21.07"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
26.57 | 25.05 | 26.81 | 25.49 | 24.22 |
| 行业(%) | 22.01 | 21.24 | 21.92 | 21.09 | 21.07 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.37","vol":"0.58"},{"date":"2025-03-31","value":"0.34","vol":"0.57"},{"date":"2024-12-31","value":"0.37","vol":"0.55"},{"date":"2024-09-30","value":"0.35","vol":"0.38"},{"date":"2024-06-30","value":"0.32","vol":"0.37"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.37 | 0.34 | 0.37 | 0.35 | 0.32 |
| 行业(%) | 0.58 | 0.57 | 0.55 | 0.38 | 0.37 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信建投证券 | 2025-10-10 | 买入 | |
| 华创证券 | 2025-09-15 | 增持 | |
| 华泰金融(HK) | 2025-09-07 | 买入 | |
| 太平洋 | 2025-09-07 | 买入 | |
| 华安证券 | 2025-09-05 | 买入 | |
| 中信证券 | 2025-08-25 | 买入 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"9.74","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"11.67","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"12.17","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"11.94","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"12.41","blueLineValue":"2.17","type":"YC"}]